Dosing of the first patient in Phase 2b marks an important transition of the RESOLVE trial from a Phase 2a open-label study ...

Medically reviewed by Jay N. Yepuri, MD Eosinophilic esophagitis (EoE) occurs when white blood cells called eosinophils build ...

Eosinophilic gastrointestinal diseases are exponentially more prevalent among patients with atopic diseases compared with the ...

The clinical-stage biotechnology company said Tuesday that the study will enroll at least 60 participants who will receive either one EP-104GI dose, two doses or a placebo. After six months, eligible ...

Eosinophilic esophagitis (EoE) is a chronic disease that causes inflammation to your esophagus, the tube that connects your mouth and stomach. It’s related to chronic allergies to either food or ...

Discover a study that highlights dupilumab’s consistent efficacy in eosinophilic oesophagitis, even among patients with ...

PR Newswire LAS VEGAS, May 15, 2025 The dynamics of the eosinophilic esophagitis market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as APT ...

Patients with eosinophilic esophagitis in the US have high health care resource utilization costs, according to a retrospective national claims study.

Eosinophilic Esophagitis: Managed through elimination diets, topical corticosteroids (swallowed not inhaled) and allergen testing. Infectious Esophagitis: Requires antifungal, antiviral or ...

Symptoms of eosinophilic esophagitis are often hard to recognize. Here’s what to look out for. Eosinophilic esophagitis (EoE) is a chronic, inflammatory disorder of the esophagus. It occurs when ...

Nat Clin Pract Gastroenterol Hepatol. 2006;3(5):285-289. In the adult population, eosinophilic esophagitis tends to be chronic, but stable, with no significant effect on morbidity or mortality ...